Nektar Therapeutics | NKTR - Assets


Nektar Therapeutics reported $301.35M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Agios Pharmaceuticals USD 1.3B 88.48M Dec/2025
ALKERMES USD 2.49B 157.48M Dec/2025
Alterity Therapeutics Limited AUD 27.32M 6.07M Jun/2023
Amgen USD 90.59B 445M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
BioCryst Pharmaceuticals USD 446.42M 10.76M Sep/2025
Biogen USD 29.44B 232M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Cara Therapeutics USD 43.75M 4.8M Jun/2025
Cipla INR 401.64B 27.77B Sep/2025
Dr.Reddys Laboratories INR 562.9B 20.89B Dec/2025
Eisai JPY 1.49T 48.22B Dec/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Esperion Therapeutics USD 364.02M 16.93M Sep/2025
Exelixis USD 2.84B 20.87M Dec/2025
Gilead Sciences USD 59.02B 490M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Grifols EUR 23.29B 3.35M Sep/2025
Halozyme Therapeutics USD 2.53B 304.09M Dec/2025
Incyte USD 6.96B 627.62M Dec/2025
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
Ironwood Pharmaceuticals USD 396.06M 53.12M Sep/2025
Karyopharm Therapeutics USD 96.23M 8.65M Sep/2025
MacroGenics USD 270.76M 25.34M Sep/2025
Merck USD 129.55B 12.02B Sep/2025
Nektar Therapeutics USD 301.35M 93.81M Sep/2025
Neurocrine Biosciences USD 4.63B 365.8M Dec/2025
Novartis USD 107.29B 2.89B Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sarepta Therapeutics USD 3.35B 143.73M Dec/2025
Takeda JPY 15.41T 938.47B Dec/2025
Teva Pharmaceutical Industries USD 40.75B 892M Dec/2025
Xencor USD 875.5M 6.68M Dec/2025